has been cited by the following article(s):
|
[1]
|
Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review)
Experimental and Therapeutic Medicine,
2021
DOI:10.3892/etm.2021.10844
|
|
|
|
|
[2]
|
Retracted
: Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.28693
|
|
|
|
|
[3]
|
Retracted
: Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.28693
|
|
|
|
|
[4]
|
Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model
Oncotarget,
2015
DOI:10.18632/oncotarget.3622
|
|
|
|
|
[5]
|
KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
BioMed Research International,
2014
DOI:10.1155/2014/747415
|
|
|
|